Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 275 publications
Integrative Proteomic Analysis Reveals VMG Oncolytic Virus-Induced Molecular Reprogramming in Pancreatic Ductal Adenocarcinoma.
Journal: Research square
Published: July 03, 2026
Phase 2 Study of Futibatinib in Combination with Pembrolizumab in Patients with FGF19 expressing Advanced Hepatocellular Carcinoma.
Journal: The oncologist
Published: June 11, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.
Journal: JCO precision oncology
Published: June 03, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Cellular Therapies in Solid Tumors: Are We Ready for Primetime?
Journal: JCO oncology practice
Published: May 20, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2026
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience.
Journal: JCO precision oncology
Published: April 09, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer.
Journal: JCO precision oncology
Published: April 03, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma.
Journal: JCO precision oncology
Published: March 25, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomas.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
Last Updated: 09/26/2026